Výsledky vyhledávání - "Yi‐Chao Geng"

Akademický článek

Simultaneous integrated boost of intensity‐modulated radiation therapy to Stage II‐III non‐small cell lung cancer with metastatic lymph nodes

Autor: Qing‐Song Li, Na Liang, Wei‐Wei Ouyang, Sheng‐Fa Su, Zhu Ma, Yi‐Chao Geng, Wen‐Gang Yang, Yin‐Xiang Hu, Hui‐Qin Li, Bing Lu

Publikováno v: Cancer Medicine, Vol 9, Iss 22, Pp 8364-8372 (2020)

Abstract Local tumor failure remains a major problem after radiation‐based nonsurgical treatment for unresectable locally advanced nonsmall cell lung cancer (NSCLC）and inoperable stage II NSCLC. The aim of this study was to evaluate the feasibili

Externí odkaz: https://doaj.org/article/eed30f0668f040f08e1293f7c9ca294f

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Prognostic Model to Predict Overall Survival for Metastatic Non-Small Cell Lung Cancer Patients Treated With Chemotherapy Combined With Concurrent Radiation Therapy to the Primary Tumor: Analysis From Two Prospective Studies

Autor: Ling-Feng Liu, Qing-Song Li, Yin-Xiang Hu, Wen-Gang Yang, Xia-Xia Chen, Zhu Ma, Wei-Wei OuYang, Yi-Chao Geng, Cheng Hu, Sheng-Fa Su, Bing Lu

Publikováno v: Frontiers in Oncology, Vol 11 (2021)

PurposeThe role of radiotherapy, in addition to chemotherapy, has not been thoroughly determined in metastatic non-small cell lung cancer (NSCLC). The purpose of the study was to investigate the prognostic factors and to establish a model for the pre

Externí odkaz: https://doaj.org/article/7a1e8fde53234de88f5f247faa62cf1b

Zobrazit plný text záznamu

Simultaneous Integrated Boost of intensity modulated radiation therapy to Stage II-III Non-Small Cell Lung Cancer with metastatic lymph nodes

Autor: qingsong li, Na Liang, Wei-Wei Ouyang, Sheng-Fa Su, Zhu Ma, Yi-Chao Geng, Wen-Gang Yang, Yin-Xiang Hu, Hui-Qin Li, Bing Lu

Background: Local tumor failure remains a major problem after radiation-based nonsurgical treatment for unresectable locally advanced Non-Small Cell Lung Cancer （NSCLC）and inoperable stage II NSCLC .The aim of this study was to evaluate the feasi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b37306cceadf1c3f3e635f45219faf3e
https://doi.org/10.21203/rs.3.rs-15993/v1

Zobrazit plný text záznamu

Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching

Autor: Shengfa Su, Weiwei Ouyang, Yu Wang, Qingsong Li, Bing Lu, Zhu Ma, Wen-Gang Yang, Daxian Luo, ChaoFen Zhao, Ling-Feng Liu, Zhixu He, Yi-Chao Geng, Mei Li

Publikováno v: Anti-cancer drugs. 30(3)

The aim of this study was to compare the clinical efficacy of pemetrexed+cisplatin (PP) versus docetaxel+cisplatin (DP) for the treatment of stage IV lung adenocarcinoma. We retrospectively analyzed the clinical data of 147 patients with stage IV lun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daa658d04b7c352612cb79d4238f1eaa
https://pubmed.ncbi.nlm.nih.gov/30489288

Zobrazit plný text záznamu